Abstract
A novel class of competitive, acylating inhibitors for the proline-specific peptidases: dipeptidyl peptidase IV, dipeptidyl peptidase II and prolyl endopeptidase, has been developed. The inhibitor molecules combine the efficacy of aminoacyl pyrrolidides and the potential transacylating capability of diacyl hydroxyl amines. The N-terminal deblocked inhibitors are potent reversible inhibitors of porcine kidney dipeptidyl peptidase IV, human placenta dipeptidyl peptidase II exhibiting Ki values in the microM range. Boc-protected (omega-N-hydroxy acyl amid) aminodiacarboxylic acid pyrrolidides inhibit substrate hydrolysis by prolyl endopeptidases from different sources competitively reaching Ki values of 30 nM to 60 microM. Additionally, alpha-N-BOC-(omega-N-hydroxy acetyl) glutaminyl pyrrolidide modifies human placenta prolyl endopeptidase in a time-dependent reaction.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Aspartic Acid / analogs & derivatives
-
Aspartic Acid / chemical synthesis*
-
Aspartic Acid / pharmacology
-
Dipeptidyl Peptidase 4
-
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / antagonists & inhibitors*
-
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / metabolism
-
Drug Design*
-
Glutamates / chemical synthesis*
-
Glutamates / pharmacology
-
Humans
-
Hydrolysis
-
Molecular Sequence Data
-
Prolyl Oligopeptidases
-
Pyrrolidines / chemical synthesis*
-
Pyrrolidines / pharmacology
-
Serine Endopeptidases / metabolism*
-
Serine Proteinase Inhibitors / chemical synthesis*
-
Swine
Substances
-
Glutamates
-
Pyrrolidines
-
Serine Proteinase Inhibitors
-
Aspartic Acid
-
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
-
dipeptidyl peptidase II
-
Dipeptidyl Peptidase 4
-
Serine Endopeptidases
-
PREPL protein, human
-
Prolyl Oligopeptidases